|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Restricted cash | |||||||||||||
| Investment in marketable securities | |||||||||||||
| Accounts receivable | |||||||||||||
| Due from vendors | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Deferred income taxes | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Goodwill | |||||||||||||
| Intangible assets, net | |||||||||||||
| Other assets | |||||||||||||
| Assets of business held for sale | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Deficit | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued liabilities | |||||||||||||
| Deferred revenue | |||||||||||||
| Funds payable to customers | |||||||||||||
| Debt, current portion | |||||||||||||
| Deferred rent and lease incentives, current portion | |||||||||||||
| Operating lease liabilities, current portion | |||||||||||||
| Total current liabilities | |||||||||||||
| Deferred income taxes, non-current portion | |||||||||||||
| Debt, non-current portion | |||||||||||||
| Deferred rent and lease incentives, non-current portion | |||||||||||||
| Deferred income taxes | |||||||||||||
| Operating lease liabilities, non-current portion | |||||||||||||
| Other liabilities | |||||||||||||
| Liabilities of business held for sale | |||||||||||||
| Total liabilities | |||||||||||||
| Redeemable convertible preferred stock, par value of $0.0001; zero shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | |||||||||||||
| Preferred stock, par value of $0.0001; 100,000,000 shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | |||||||||||||
| Stockholders’ deficit: | |||||||||||||
| Common stock | |||||||||||||
| Class A Common Stock | |||||||||||||
| Class B Common Stock | |||||||||||||
| Class C common stock (authorized March 15, 2021), par value of $0.0001; zero shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | |||||||||||||
| Class C Common Stock | |||||||||||||
| Additional paid in capital | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ deficit | |||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||
| Common stock, outstanding (in shares) | |||||||||||||
| Class A Common Stock | |||||||||||||
| Class B Common Stock | |||||||||||||
| Class C common stock (authorized March 15, 2021), par value of $0.0001; zero shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | |||||||||||||
| Class C Common Stock | |||||||||||||
| Common stock, issued (in shares) | |||||||||||||
| Class A Common Stock | |||||||||||||
| Class B Common Stock | |||||||||||||
| Class C common stock (authorized March 15, 2021), par value of $0.0001; zero shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding as of December 31, 2023 and 2022, respectively | |||||||||||||
| Class C Common Stock |
Loading...
